| 000 | 00946 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250518004231.0 | ||
| 264 | 0 | _c20200406 | |
| 008 | 202004s 0 0 eng d | ||
| 022 | _a1468-2060 | ||
| 024 | 7 |
_a10.1136/annrheumdis-2018-214516 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCharles, Pierre | |
| 245 | 0 | 0 |
_aResponse to: '"MAINRITSAN2-the future", with some doubts!' by Chattopadhyay _h[electronic resource] |
| 260 |
_bAnnals of the rheumatic diseases _c12 2019 |
||
| 300 |
_ae140 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis |
| 650 | 0 | 4 | _aGranulomatosis with Polyangiitis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aRituximab |
| 700 | 1 | _aGuillevin, Loic | |
| 773 | 0 |
_tAnnals of the rheumatic diseases _gvol. 78 _gno. 12 _gp. e140 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/annrheumdis-2018-214516 _zAvailable from publisher's website |
| 999 |
_c28984093 _d28984093 |
||